Work

Supplementary Figure 5 from Telomerase upregulation induces progression of mouse BrafV600E-driven thyroid cancers and triggers non-telomeric effects

Year: 2024

Type: supplementary-materials

Abstract: In vivo dabrafenib plus trametinib treatment of mice.

DOI: 10.1158/1541-7786.27035422

Authors: Inigo Landa, Caitlin EM Thornton, Bin Xu, Jacob Haase, Gnana P. Krishnamoorthy, Jingzhu Hao, Jeffrey A. Knauf, Zachary T. Herbert, Paula Martínez, Maria A. Blasco, Ronald Ghossein, James A. Fagin

Language: English

Topic: Thyroid Cancer Diagnosis and Treatment

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4402768356

Cites:

Cited by:

Related to: